Background and objectives Sudden cardiac death is the most common cause of death among individuals undergoing hemodialysis. The epidemiology of sudden cardiac death has been well studied, and efforts are shifting to risk assessment. This study aimed to test whether assessment of acute changes during hemodialysis that are captured in electronic health records improved risk assessment. died on the day of or day after a dialysis session that was serving as a training or test data session, respectively. A reasonably strong predictor was derived using just predialysis information (concordance statistic=0.782), which showed modest but significant improvement after inclusion of postdialysis information (concordance statistic=0.799, P,0.001). However, risk prediction decreased the farther out that it was forecasted (up to 1 year), and postdialytic information became less important.
Introduction
It is well recognized that patients undergoing hemodialysis (HD) are at increased risk of serious cardiovascular events. Cardiac disease accounts for 43% of all-cause mortality, with approximately 61% of those deaths caused by sudden cardiac arrest (SCA) (1) . Significant work has been undertaken to understand the epidemiology of and identify risk factors for SCA (2) (3) (4) (5) (6) (7) (8) (9) (10) . Many of the risk factors identified, including lower ultrafilitration volume, low calcium dialysate, and shorter treatment time, are readily captured by electronic health record (EHR) systems.
After risk factors are identified, the information can be used to develop risk prediction tools. Some work in this area has occurred, particularly looking at long-term risk (9) . However, the assessment of short-term risk is potentially of greater impact, which has become a point of emphasis for the National Heart, Lung, and Blood Institute (NHLBI) (11, 12) . With the growing incorporation of EHR systems into HD settings (13) , there is the potential to capture important factors in real time, ultimately allowing for the development of near-term risk predictions tools.
The purpose of this analysis is to examine the potential of EHRs for predicting the near-term risk of sudden cardiac death (SCD) after the completion of an HD session. Specifically, we ask three questions. (1) Can a model be derived for predicting SCD on the day of and day after a dialysis session? (2) Do factors collected during and after the dialysis session improve risk assessment? (3) How far in advance can SCD be reliably predicted? We use modern methods in statistical learning to develop the risk prediction tools.
Materials and Methods

Cohort
All dialysis treatments received by patients over the age of 66 years at DaVita Inc. between 2004 and 2008 were available for analysis. DaVita Inc. is a national for-profit dialysis provider, where currently, more than 100,000 patients receive their treatment. To capture a fully representative cohort, all individuals receiving HD were eligible for study inclusion, and there were no exclusions for history of SCA or presence of an implant device.
Predictors
Using data solely from the DaVita Inc. EHRs, we abstracted information on demographic factors (age, sex, and race/ethnicity [white, black, Asian, Hispanic, and other]), dialysis-specific factors (date of dialysis session, calcium and potassium dialysate concentrations, blood flow rate, dialysate flow rate, and length of dialysis session), laboratory values (serum albumin, serum bicarbonate, serum creatinine, serum phosphorous, serum potassium, serum iron, single-pool Kt/V, equilibrated Kt/V, serum calcium, white blood cell count, hematocrit, hemoglobin, platelet count, serum ferritin, and biointact parathyroid hormone), biometric factors (pre-and postdialysis weight and pre-and postdialysis systolic and diastolic BP), and dose of administered intravenous medications (erythropoietin, heparin, and vitamin D agents) and hemodynamic factors (systolic and diastolic BP and pulse pressure). Several other variables were derived from the available data. They included days since dialysis initiation, days since last dialysis session, month and day of week, change in weight from the end of the last HD session, liters of fluid removed per minute, difference between actual and prescribed run time, pre-and postdialysis pulse pressure, pre-and postmean arterial pressure, and change in hemodynamic measures. Also, because laboratory tests were done semiregularly (using prespecified intervals dependent on the specific parameter [generally every 2-8 weeks]), time since the laboratory result was added as a covariate. In total, 72 predictors were considered and grouped into pre-and postdialysis variables (Table 1) . To assess the potential of an EHR system to assess risk, we did not add any other outside covariate (i.e., from the US Renal Data System [USRDS]).
Outcome
The outcome of interest was a recorded SCD on the day of or day after completing a dialysis session, which was defined in the DaVita Inc. EHR system. Because patients generally receive outpatient HD every other day, this outcome represents the time between HD visits. Previous work has shown that ascertainment of SCD from death records is relatively high, with a sensitivity of 83% and specificity of 95% (14) . However, because exact timing of SCD is not recorded, it is not generally possible to differentiate between those patients who had an arrest during HD and those patients who had an arrest after completion (our population of interest). Previous work has shown that approximately 5 of 100,000 HD sessions result in an incenter SCD (15) . To exclude events that occurred during the HD session, we required that postdialytic information (e.g., BP and weight) be present.
Analyses
Data Splitting. We divided the data into training and validation sets. The training set consisted of all dialysis sessions after which an SCD event occurred from 2004 to 2006. An equal number of nonevent dialysis sessions was randomly selected from the same years. Although other ratios of events to nonevents were explored (Sensitivity Analyses), a one-to-one scheme was prioritized, because it easily allows one to interpret a predicted probability above 50% as greater than average risk and one to interpret a predicted probability less than 50% as below average risk. Aside from year, no explicit matching was used. The same individual was eligible to serve as both a control (nonevent) and a case (event), reflecting a nested case control design. The validation data consisted of all events and an equal number of randomly selected nonevents from 2007 to 2008.
To explore the ability to predict SCD at longer follow-up time points, training and validation sets were derived as above, where the outcome was defined as SCD within 7, 30, 90, 180, and 365 days of the dialysis session; 1500 HD sessions (750 each of events and nonevents) were selected for the training set, and 1000 sessions (500 each of events and nonevents) were selected for the validation set. Because individuals may have left the DaVita Inc. network within the predicted time frame, date and cause of death were determined through linkage with the USRDS.
Generating Predictions. Our primary objective was to derive an optimal predictor of SCD. A wide range of algorithms is available for predicting the probability of an event, and these algorithms were explored for suitability (Sensitivity Analyses). Based on the current data problem, we chose the Random Forests (RF) algorithm to serve as the primary prediction tool in this study (16) . In brief, RF is a collection of decision trees combined by bootstrapping (called bagging) to create a more robust and stable predictor (Supplemental Appendix). Generally, one grows hundreds or thousands of trees to generate an overall prediction. In classification settings, the predicted probability is the average number of trees that votes for each outcome. RF has been used successfully in many settings, most notably statistical genetics (17) . A priori, we considered, based on the predictor variables, that our data-generating distribution likely contained many conditional effects. Because at its core, RF is a series of decision trees, it is well suited for such a scenario. Although there are multiple tuning parameters, RF is relatively robust to their settings. The optimal settings were selected by minimization of the out-of-bag error rate, an internal error rate that behaves similarly to crossvalidation.
Outlying and Missing Data. An advantage of RF, like most tree-based algorithms, is that it is robust to outlying values. Liberal values were used for determining outlying clinical measurements (Table 1 ). Any outlying values or missing data were then imputed using the RF-based imputation, which is similar to an iterated nearest-neighbor-based algorithm (18) .
Variable Importance. Like many machine learning algorithms, RF does not allow for formal inference on the association of the predictor variables with the outcome. However, RF does have multiple ad hoc variable importance metrics that allow for relative rankings of the variables. We used the permutation importance to rank the variables from each prediction model. The permutation importance calculates the increase in misclassification when the variable of interest is permuted and can be interpreted as the importance of that variable to the predictability of the overall model (17) .
Prediction Evaluation. Concordance (c) statistics and associated receiver operator characteristic (ROC) curves were calculated. Improvement in ROC curves was performed using the method by Delong et al. (19) . Reclassification was also assessed by the integrated discrimination index (IDI) (20) . All analyses were performed in R 2.14 (21) , and the RF library was used for RF predictions (22) .
Sensitivity Analyses. Several sensitivity analyses were undertaken. First, different machine learning algorithms were compared. They included logistic regression, regularized regression (LASSO), nearest neighbors, and Classification and Regression Tree (CART). Second, we also explored higher ratios of nonevents to events using 2:1, 5:1, and 10:1. The algorithm and settings that minimized a crossvalidated error rate in the training data were selected and tested on the validation data.
This work was conducted under data use agreements between W.C.W., DaVita Inc., and the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK). This research was approved by an Institutional Review Board of Stanford University. Publication was approved by both DaVita Inc. and the NIDDK.
Results
Between (Figure 1 ). Of these individuals, 8827 (7.1%) individuals died of SCD during the same time period, accounting for 20% of all deaths during the study period. For the training set (2004) (2005) (2006) , 898 people died on the day of or day after a dialysis session. The median time from last outpatient HD session to death was 4 days. An equal number of nonevent dialysis sessions was randomly selected. Individuals on the day of an event session were slightly older, had spent less time on dialysis, and had slightly lower weight than the patients selected in the nonevent sessions (Table 2 ). In the training data, there were significant differences in all hemodynamic measures, with those individuals experiencing an event having lower initial BP and a smaller change in BP. Many of the laboratory measures were not significantly different, with the notable exception of albumin and parathyroid hormone, which were both lower in patients who had an event ( Table 2) .
Pre-Versus Postdialytic Information
Using the training data, two RFs were grown with 2000 trees: one RF using just predialysis information and one RF incorporating postdialysis information in addition to the predialysis information. For the test data, 826 event sessions Figure 1 . | Case inclusion/exclusion for training and test sets. An equal number of noncases was selected as the control. HD, hemodialysis; SCD, sudden cardiac death. Figure 2 . Both models showed good discrimination (c statistic=0.799 versus 0.782); however, incorporation of the postdialysis information did significantly improve the ROC curve (P,0.001) and resulted in a significant increase in reclassification (IDI=0.02, P,0.001).
Longer-Term Prediction
We created training and validation sets to predict SCD at 7, 30, 90, 180, and 365 days after a dialysis session. The ROC curves for six models (including 1 day out) are shown in Figure 3 . The quality of the predictions decreases as the time horizon for SCD increases. Moreover, postdialytic factors provide less additional information in the later models. Table 3 shows the c statistics and IDIs for six models and the associated improvements both with and without postdialytic information. There is significant improvement in prediction of SCD when adding postdialytic factors when predicting 1 and 7 days out but not when making longer-term predictions.
Important Variables
One of the appeals of RF is the ability to detect important or influential variables. Unlike traditional regression models, these metrics do not have any notion of statistical significance but instead, represent the relative importance of the variable to the prediction model. Table 4 shows the top six variables for each of the six models. There is a high degree of overlap among the top predictors. For predicting SCD within the next 1 or 7 days, all of the top variables (aside from serum albumin) are those variables that were most variable from session to session. stable measures of health (i.e., additional laboratory values, erythropoiesis stimulating agent dose, and weight).
Sensitivity Analyses
Several sensitivity analyses were undertaken. First, different machine learning algorithms were compared. Most of these algorithms showed similar performance, although RF had the best crossvalidated and test set loss (Supplemental Figure 1) . Second, we also explored higher ratios of controls to cases. The inclusion of additional controls did not significantly improve prediction (Supplemental Figure 2) .
Discussion
Our work is the first to show that acute changes during the dialysis process can be used to predict near-term risk of SCD. This step is a first step to addressing the call by the NHLBI to develop prediction tools for near-term risk of cardiac events (11, 12) . As computational power improves, EHRs are becoming more important, because they allow for the real-time monitoring of patients. Based on our anecdotal experiences, many clinicians view EHRs as a rather cumbersome tool and use them primarily to meet various billing documentation requirements for full reimbursement. However, as predictive medicine improves, EHRs will become a dynamic tool that may actually improve patient care in real time. Although few studies have analyzed real-time data, studies that have are proven successful (23) (24) (25) (26) .
Our results show that there is meaningful information in the data to predict the risk of SCD within the next day. Even before the dialysis session begins, a reasonably strong predictor can be created with the information available at the time. However, after incorporating information collected during and after the dialysis session, the predictor showed moderate but significant improvement, achieving a c statistic of 0.80 on our validation data. More interestingly, the variables that were shown to be important to near-term prediction are those variables that are most dynamic across dialysis sessions, including BP and intradialytic weight change. The notable exception was serum albumin, which is a relatively more stable measure. Not surprisingly, the quality of the predictions decreases with increasingly longer time horizons. Our EHR dataset contains extensive information on changing hemodynamics. It is more likely that information, such as changing BP, is more beneficial for assessing near-term risk than longerterm risk. Looking at both the change in c statistics and the important predictor variables for each model confirms this assessment. When forecasting out 30 days or more, the model is not significantly improved by the incorporation of postdialytic variables. Moreover, although the top predictor variables from the nearer-term models (,30 days) primarily consist of hemodynamic factors (with the exception of serum albumin, a general marker of poor health) (27) , the later-term models incorporate other less mutable factors, including erythoropoiesis stimulating agent dose and additional laboratory measures. However, we note that hemodynamic factors were still important to these longer-term models. Previous work has shown BP variability to be an important correlate of cardiovascular outcomes (28) (29) (30) . Overall, these results suggest that the EHR data are not only suitable for near-term prediction but in fact, optimal for it.
Although this study presents encouraging information regarding the potential to predict near-term SCD, there are still several challenges. Even among a population with a relatively high incidence of SCD, SCD remains a relatively rare event (at about 1 per 10,000 sessions) in our population. Interestingly, most SCDs occur 4 days or more after the most recent outpatient HD session. This finding suggests that patients are experiencing their SCD within a hospital setting, perhaps as a result of other extenuating health factors. Although the prevalence of the outcome does not impact sensitivity and specificity, it does have a direct relationship with positive predictive value (PPV), which is generally a more meaningful indicator of clinical use. Given the observed sensitivity and specificity and low prevalence, the best PPV that we could expect to achieve would be about 0.04%, a cutoff that indicates that there would be more than 2500 false positives for each correct identification. The two ways to increase the PPV are improve the quality of the predictor and improve the incidence of the outcome. Although we are able to create a relatively strong predictor (as measured by c statistics), there is still room to incorporate additional information that is not readily available in the EHR system. Moreover, future works should aim to better leverage the available data, taking advantage of the longitudinal nature of the data. Unfortunately, increasing the incidence of the event seems less promising. Forecasting farther out (which would increase the cumulative incidence) results in a worse predictor. Another way to increase the incidence would be to broaden the outcome definition by including other types of cardiac events (e.g., myocardial infarction) or even all-cause mortality. However, because the outcome becomes more heterogeneous, the quality of the predictor would likely decrease, and the specific necessary intervention would become less clear, limiting the use of the prediction tool in a real world environment.
Our study has several strengths. Our work constitutes one of the largest investigations of EHR dialysis data. We had access to over 100,000 people contributing 22 million HD sessions over 5 years. Using this large amount of data, we were able to abstract over 1600 HD sessions that were followed by an SCD. We took advantage of the large amount of data to create training and test sets, providing confidence that our prediction models are not overfit. Recognizing the likely complex relationship within the data, we used sophisticated methodology to create our prediction models, relying on the RF algorithm. The RF algorithm has also been used successfully in other settings, most notably statistical genetics (17) , but it has seen much less use in clinical medicine. As data become more complex, it is important to apply the appropriate tools to capture this complexity.
Our study also has several limitations. Although our dataset is relatively dense, we could not capture many other important predictors using the EHR available to us. The most notable lacking variables were comorbid conditions and oral medications. For example, we did not This finding may partially explain why the longer-term prediction models performed more poorly than the nearerterm models. Some of this information can be captured through linkage with alternative sources, and if informative, it can be used to inform improvement in the EHR. There is also the potential to more fully use the longitudinal nature of the data, because our models only used information from that specific dialysis session. However, people generally receive HD over months and years, allowing for the incorporation of much more information. Finally, we were also limited in our ability to ascertain the outcome, because we could only identify SCA that led to death and could not identify nonfatal SCA. Including such events may have influenced the performance of our prediction models. Particularly, it would have increased the incidence of the outcome, improving the PPV. However, in the population, SCA outside of clinical facility is generally fatal.
In conclusion, our work illustrates both some of the possibilities and some of the challenges of using EHRs to predict near-term cardiac events. Current clinical practice involves dealing with serious adverse events, such as SCD, only after they occur. Our study underscores how acute changes during dialysis may identify key factors in predicting the near-term risk of SCD and that data from EHRs contain enough granular information to generate a strong predictor. Ultimately, the relative rarity of SCD and many other cardiac events makes deriving a clinically useful tool a challenge; however, this approach could easily be extended to predict other important clinical events.
